| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.37B | 2.15B | 1.95B | 1.82B | 1.81B | 1.86B |
| Gross Profit | 1.61B | 2.00B | 1.66B | 754.10M | 874.30M | 908.40M |
| EBITDA | 1.32B | 1.19B | 992.70M | 1.18B | 1.16B | 1.02B |
| Net Income | 401.60M | 264.70M | 126.90M | 204.90M | 453.40M | 106.80M |
Balance Sheet | ||||||
| Total Assets | 17.53B | 16.77B | 15.65B | 14.53B | 14.18B | 14.04B |
| Cash, Cash Equivalents and Short-Term Investments | 1.94B | 1.67B | 1.40B | 340.40M | 744.10M | 528.10M |
| Total Debt | 11.38B | 10.79B | 10.00B | 8.44B | 8.45B | 8.36B |
| Total Liabilities | 15.54B | 14.77B | 13.60B | 12.02B | 11.15B | 11.08B |
| Stockholders Equity | 1.99B | 2.00B | 2.06B | 2.51B | 3.03B | 2.96B |
Cash Flow | ||||||
| Free Cash Flow | -58.70M | -79.90M | -19.00M | 93.50M | 221.80M | 135.20M |
| Operating Cash Flow | 1.13B | 918.10M | 745.10M | 787.50M | 865.80M | 815.20M |
| Investing Cash Flow | -876.10M | -987.20M | -731.40M | -593.40M | -555.70M | -598.80M |
| Financing Cash Flow | 151.00M | 358.80M | 1.04B | -85.00M | -89.70M | -27.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £69.60B | 23.75 | 7.87% | 4.15% | -9.52% | 35.74% | |
74 Outperform | £32.46B | 30.88 | 9.92% | 2.98% | 1.78% | -50.72% | |
72 Outperform | £9.49B | 23.65 | 20.43% | 4.45% | 15.76% | 254.82% | |
71 Outperform | £9.85B | 31.21 | 17.41% | 4.50% | 10.68% | 35.18% | |
67 Neutral | £2.81B | 95.69 | 2.50% | 6.56% | 19.50% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
59 Neutral | £8.88B | -174.07 | -5.95% | 2.86% | -4.82% | -123.58% |